The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses

被引:43
作者
Kiura, Kazuto
Kataoka, Hideo
Yasuda, Motoaki
Inoue, Nobuo
Shibata, Ken-ichiro
机构
[1] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Kita Ku, Sapporo, Hokkaido 0608586, Japan
[2] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Kita Ku, Sapporo, Hokkaido 0608586, Japan
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2006年 / 48卷 / 01期
关键词
adjuvant; Th2; response; toll-like receptor 2; lipopeptide; lipopolysaccharide;
D O I
10.1111/j.1574-695X.2006.00119.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The diacylated lipopeptide FSL-1 enhanced the generation of IgG antibodies in TLR2(+/+) mice, but not in TLR2(-/-) mice, when administered together with hen egg lysozyme as an antigen. Escherichia coli lipopolysaccharide enhanced the generation of antigen-specific antibodies in both TLR2(-/-) and TLR2(+/+) mice. In TLR2(+/+) mice, the level of enhancement due to FSL-1 was similar to that caused by lipopolysaccharide. Analysis of the IgG antibodies subclass demonstrated that the level of Th2-type IgG1 antibodies was higher than that of Th1-type IgG2a antibodies. Both FSL-1 and lipopolysaccharide induced production of IL-10 and IL-6 by splenocytes from TLR2(+/+) mice. Lipopolysaccharide also induced production of these cytokines by splenocytes from TLR2(-/-) mice, but FSL-1 did not. Neither FSL-1 nor lipopolysaccharide induced IL-12p70 production by splenocytes from either type of mice. FSL-1 upregulated B7.2 expression in B220(+) cells from TLR2(+/+) mice but not those from TLR2(-/-) mice, whereas lipopolysaccharide upregulated B7.2 expression in B220(+) cells from both types of mice. FSL-1 and, to a lesser extent, lipopolysaccharide activated mitogen-activated protein kinases in splenocytes. FSL-1 and, to a lesser extent, lipopolysaccharide induced the expression of c-Fos, which is known to be involved in Th2-type responses, in splenocytes. Thus, this study demonstrated that FSL-1 possessed TLR2-mediated Th2-type responses in vivo.
引用
收藏
页码:44 / 55
页数:12
相关论文
共 39 条
[1]   Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis [J].
Akiba, H ;
Miyahira, Y ;
Atsuta, M ;
Takeda, K ;
Nohara, C ;
Futagawa, T ;
Matsuda, H ;
Aoki, T ;
Yagita, H ;
Okumura, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :375-380
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   Development of immunoadjuvants for immunotherapy of cancer [J].
Azuma, I ;
Seya, T .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (07) :1249-1259
[4]   Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization [J].
Baier, W ;
Masihi, N ;
Huber, M ;
Hoffmann, P ;
Bessler, WG .
IMMUNOBIOLOGY, 2000, 201 (3-4) :391-405
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Control of adaptive immune responses by Toll-like receptors [J].
Barton, GM ;
Medzhitov, R .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (03) :380-383
[7]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[8]   Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation [J].
Boonstra, A ;
Asselin-Paturel, C ;
Gilliet, M ;
Crain, C ;
Trinchieri, G ;
Liu, YJ ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) :101-109
[9]   Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response [J].
Didierlaurent, A ;
Ferrero, I ;
Otten, LA ;
Dubois, B ;
Reinhardt, M ;
Carlsen, H ;
Blomhoff, R ;
Akira, S ;
Kraehenbuhl, JP ;
Sirard, JC .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6922-6930
[10]   A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells [J].
Dillon, S ;
Agrawal, A ;
Van Dyke, T ;
Landreth, G ;
McCauley, L ;
Koh, A ;
Maliszewski, C ;
Akira, S ;
Pulendran, B .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4733-4743